cigna glp-1 coverage news today Obesity Drugs: drops of GLP-1 obesity drugs for its own employees: What's the future of weight-loss treatment Online Weight Loss Covered by

A 2025 study titled Ocular Adverse Events Associated with GLP-1 Receptor Agonists: A Real-World Study Based on the FAERS Database and Network Pharmacology found that GLP-1 medication was associated with ocular adverse events such as blurred vision, visual impairment, and diabetic retinopathy

Cultural attitudes toward obesity as a condition requiring pharmacological intervention also remain more conservative than in Western markets

Campbells CEO Mick Beekhuizen said in an earnings call this week that canned soup sales are soaring, likely as a result of tighter food budgets and consumers deciding to cook at home instead of going out to eat

30 March 2026

These expanded uses position GLP-1s as multi-system therapies, not just treatments for diabetes or high obesity rates